A

Accelerate@Babraham

Europe, Cambridgeshire, United Kingdom, Cambridge

Description

Accelerate@Babraham is the incubation programme of the Babraham Research Campus.

Investor Profile

Accelerate@Babraham has backed more than 11 startups, with 5 new investments in the last 12 months alone. The firm has led 10 rounds, about 91% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Pre Seed rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.
  • Led 5 rounds in the past year.

Stage Focus

  • Grant (91%)
  • Pre Seed (9%)

Country Focus

  • United Kingdom (82%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical
  • Biopharma
  • Machine Learning
  • Genetics
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Alternative Protein
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Accelerate@Babraham frequently co-invest with?

Deep Science Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Avonmore Developments
Europe, England, United Kingdom, London
Co-Investments: 1
Cambridge Angels group
Europe, England, United Kingdom, London
Co-Investments: 1
O2h Ventures
Europe, Cambridgeshire, United Kingdom, Hauxton
Co-Investments: 1
KQ Labs
Europe, England, United Kingdom, London
Co-Investments: 1
University of Cambridge Enterprise
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 1
Illumina
North America, California, United States, San Diego
Co-Investments: 1
R42 Group
North America, California, United States, Stanford
Co-Investments: 1

What are some of recent deals done by Accelerate@Babraham?

Cycle Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Cycle Therapeutics is to enhancing women's quality of life by offering a fresh approach to therapeutic research.

Biotechnology
GrantJun 12, 2025
Amount Raised: $13,629

AmnioCam is a stem cell-based alternative to amniotic cells taken from placental donors.

BiotechnologyCosmeticsTherapeutics
GrantJun 12, 2025
Amount Raised: $13,629

MabGalaxy is leveraging artificial intelligence and the natural immune system to speed up the development of new antibody medications.

GrantJun 12, 2025
Amount Raised: $13,629
Sysora Health

Saint Neots, Cambridgeshire, United Kingdom

Sysora Health to eliminate Porphyromonas gingivalis while maintaining healthy oral bacteria.

Biotechnology
GrantJun 12, 2025
Amount Raised: $13,629
AAB Research

Nottingham, Nottingham, United Kingdom

AAB Research is developing engineered extracellular vesicles as a scalable and cost-effective alternative to CAR T-cell therapy.

BiopharmaBiotechnologyMedical
GrantJun 12, 2025
Amount Raised: $13,629
Concr

London, England, United Kingdom

Astrophysics technology for precision therapy through accurate modelling of biology

BiopharmaBiotechnologyMachine Learning
Pre SeedApr 1, 2021
Amount Raised: $691,491
Kalium Health

Cambridge, Cambridgeshire, United Kingdom

Patient-centric kidney disease management

Health Care
GrantJul 12, 2018
Amount Raised: $30,000
Oppilotech

London, England, United Kingdom

Developing the next generation of antibiotics with novel mechanisms of action.

BiotechnologyGeneticsHealth CareLife ScienceMedicalPharmaceutical
GrantJul 12, 2018
Amount Raised: $26,357
VisusNano

Stevenage, Herefordshire, United Kingdom

Revolutionising Treatment for Cataracts

BiotechnologyHealth CareMedical
GrantJul 12, 2018
Amount Raised: $26,357
Antiverse

Cardiff, Cardiff, United Kingdom

Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.

Artificial Intelligence (AI)BiotechnologyHealth CareLife ScienceMachine Learning
GrantJul 12, 2018
Amount Raised: $26,357